Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Ownership - Who Owns Relay Therapeutics?

397 Followers

Relay Therapeutics (RLAY) Ownership Overview

3.10%15.51%0.07%14.34%66.98%
0.07% Other Institutional Investors
14.34% ETFs
66.98% Public Companies and
Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 29.91% of the company’s stock is owned by Institutional Investors, 3.10% is owned by Insiders, and 66.98% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 01, 2024
Peter Rahmer
Chief Corporate Development Officer
xxxxxxxxxxxxx
$1840
Oct 01, 2024
xxxxxxxxxxxxx
$2215
Oct 01, 2024
Donald A Bergstrom
President, R&d
xxxxxxxxxxxxx
$4866
Oct 01, 2024
xxxxxxxxxxxxx
$2215

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$304497
Jun 30, 2024
xxxxxxxxxxxxx
$315444
Jun 30, 2024
xxxxxxxxxxxxx
$701343
Jun 30, 2024
xxxxxxxxxxxxx
$1783976

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,711,059Institution8.44%82,540,575
10,282,812Institution6.33%61,902,528
5,032,897Institution3.10%30,298,040
2,128,033Insider1.31%12,810,759
2,073,166Institution1.28%12,480,459
2,051,894Institution1.26%12,352,402
1,613,462Institution0.99%9,713,041
1,214,260Institution0.75%7,309,845
1,160,117Institution0.71%6,983,904
1,147,502Institution0.71%6,907,962

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,282,812Institution6.33%61,902,528
2,073,166Institution1.28%12,480,459
1,613,462Institution0.99%9,713,041
1,214,260Institution0.75%7,309,845
1,147,502Institution0.71%6,907,962
992,831Institution0.61%5,976,843
988,508Institution0.61%5,950,818
781,324Institution0.48%4,703,570
681,773Institution0.42%4,104,273
573,034Institution0.35%3,449,665

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,889,947Institution3.01%34,620,825
3,868,904Institution2.38%27,391,840
2,581,335Institution1.59%15,539,637
2,130,528Institution1.31%15,084,138
1,894,249Institution1.17%13,411,283
1,916,128Institution1.18%11,860,832
934,527Institution0.58%5,625,853
788,684Institution0.49%4,747,878
608,576Institution0.37%3,767,085
455,131Institution0.28%3,222,327

FAQ

Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 3.10% is held by insiders, and 66.98% is held by retail investors.
    What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.07% of Relay Therapeutics (RLAY) stock is held by institutional investors.
      What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 66.98% of Relay Therapeutics (RLAY) stock is held by retail investors.
        Who owns the most shares of Relay Therapeutics (RLAY)?
        Vanguard owns the most shares of Relay Therapeutics (RLAY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis